Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

BRCA2 mutation + ER positive

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

BRCA2 mutation (200)

BRCA wild-type (19)

ER mutation (18)

ESR1 mutation (9)

ER positive + ESR1 mutation (6)

BRCA1 mutation + BRCA2 mutation (4)

BRCA2 A902fs*2 (3)

ER negative + PIK3CA H1047R (2)

PIK3CA mutation + ESR1 mutation (2)

BRCA2 mutation + CHEK2 mutation (2)

BRCA2 mutation + TP53 mutation (2)

BRCA2 rearrangement (2)

ER D538G + ER F404L (1)

ER E380Q + ER F404L (1)

ER rs2234693 (1)

ESR1 rs1801132 (1)

ESR1 rs2228480 (1)

ESR1 rs2234693T>C (1)

ESR1 rs9322354 (1)

HR positive + PIK3CA H1047R (1)

HR positive + PIK3CA H1047R + ER D538G (1)

HR positive + PIK3CA H1047R + PIK3CA D350G + ER D538G (1)

PIK3CA H1047R + PIK3CA D959N + ER E380Q (1)

PIK3CA mutation + ER mutation (1)

APC mutation + BRCA2 mutation (1)

BRCA2 1153insT (1)

BRCA2 5396insC (1)

BRCA2 I2315T (1)

BRCA2 L557* (1)

BRCA2 N255fs + D252fs (1)

BRCA2 Y1655* + TP53 mutation (1)

BRCA2 biallelic inactivation (1)

BRCA2 mutation + ATM mutation (1)

BRCA2 mutation + CDK12 mutation (1)

BRCA2 mutation + SPOP mutation (1)

BRCA2 mutation + TP53 D816Y (1)

CHEK2 mutation + ATM mutation + BRCA2 mutation (1)

EGFR exon 19 deletion + BRCA2 mutation (1)

HER-2 negative + HR positive + ESR1 mutation + PIK3CA mutation (0)

BRCA2 E260fs (0)

BRCA2 N255_R259delinsIK (0)

BRCA2 N255fs (0)

BRCA2 N255fs + BRCA2 N255_R259delinsIK + BRCA2 E260fs (0)

BRCA2 mutation (200)

BRCA wild-type (19)

ER mutation (18)

ESR1 mutation (9)

ER positive + ESR1 mutation (6)

BRCA1 mutation + BRCA2 mutation (4)

BRCA2 A902fs*2 (3)

ER negative + PIK3CA H1047R (2)

PIK3CA mutation + ESR1 mutation (2)

BRCA2 mutation + CHEK2 mutation (2)

BRCA2 mutation + TP53 mutation (2)

BRCA2 rearrangement (2)

ER D538G + ER F404L (1)

ER E380Q + ER F404L (1)

ER rs2234693 (1)

ESR1 rs1801132 (1)

ESR1 rs2228480 (1)

ESR1 rs2234693T>C (1)

ESR1 rs9322354 (1)

HR positive + PIK3CA H1047R (1)

HR positive + PIK3CA H1047R + ER D538G (1)

HR positive + PIK3CA H1047R + PIK3CA D350G + ER D538G (1)

PIK3CA H1047R + PIK3CA D959N + ER E380Q (1)

PIK3CA mutation + ER mutation (1)

APC mutation + BRCA2 mutation (1)

BRCA2 1153insT (1)

BRCA2 5396insC (1)

BRCA2 I2315T (1)

BRCA2 L557* (1)

BRCA2 N255fs + D252fs (1)

BRCA2 Y1655* + TP53 mutation (1)

BRCA2 biallelic inactivation (1)

BRCA2 mutation + ATM mutation (1)

BRCA2 mutation + CDK12 mutation (1)

BRCA2 mutation + SPOP mutation (1)

BRCA2 mutation + TP53 D816Y (1)

CHEK2 mutation + ATM mutation + BRCA2 mutation (1)

EGFR exon 19 deletion + BRCA2 mutation (1)

HER-2 negative + HR positive + ESR1 mutation + PIK3CA mutation (0)

BRCA2 E260fs (0)

BRCA2 N255_R259delinsIK (0)

BRCA2 N255fs (0)

BRCA2 N255fs + BRCA2 N255_R259delinsIK + BRCA2 E260fs (0)

›

BRCA2 mutation + ER positive

HER2 Negative Breast Cancer

Sensitive: C3 – Early Trials

Sensitive: C3 – Early Trials